{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:44:14Z","timestamp":1768311854550,"version":"3.49.0"},"reference-count":123,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2022.13398","type":"journal-article","created":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T12:35:46Z","timestamp":1656074146000},"source":"Crossref","is-referenced-by-count":4,"title":["IDH2: A novel biomarker for environmental exposure in blood circulatory system disorders (Review)"],"prefix":"10.3892","volume":"24","author":[{"given":"Ya","family":"Gong","sequence":"first","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Cui","sequence":"additional","affiliation":[{"name":"Institute of Cardiovascular Disease, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Yan","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, The Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Qin","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lan","family":"Yi","sequence":"additional","affiliation":[{"name":"Institute of Cytology and Genetics, The Hengyang Key Laboratory of Cellular Stress Biology, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Hengyang Medical School, University of South China, Hengyang, Hunan 421001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,6,24]]},"reference":[{"key":"key20220803125959_b1-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann Oncol"},{"key":"key20220803125959_b2-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"979","DOI":"10.2217\/fon-2017-0523","article-title":"The role of IDH mutations in acute myeloid leukemia","volume":"14","author":"Montalban-Bravo","year":"2018","journal-title":"Future Oncol"},{"key":"key20220803125959_b3-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/1568026618666180518091144","article-title":"Development of novel therapeutics targeting isocitrate dehydrogenase mutations in cancer","volume":"18","author":"Sharma","year":"2018","journal-title":"Curr Top Med Chem"},{"key":"key20220803125959_b4-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/2050-7771-2-18","article-title":"Mutations in the isocitrate dehydrogenase 2 gene and IDH1 SNP 105C > T have a prognostic value in acute myeloid leukemia","volume":"2","author":"Willander","year":"2014","journal-title":"Biomark Res"},{"key":"key20220803125959_b5-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"33946","DOI":"10.1074\/jbc.M404298200","article-title":"Structures of human cytosolic NADP-dependent isocitrate dehydrogenase reveal a novel self-regulatory mechanism of activity","volume":"279","author":"Xu","year":"2004","journal-title":"J Biol Chem"},{"key":"key20220803125959_b6-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/leu.2016.275","article-title":"Isocitrate dehydrogenase mutations in myeloid malignancies","volume":"31","author":"Medeiros","year":"2017","journal-title":"Leukemia"},{"key":"key20220803125959_b7-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1158\/1078-0432.CCR-13-1333","article-title":"Molecular pathways: Isocitrate dehydrogenase mutations in cancer","volume":"22","author":"Clark","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key20220803125959_b8-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"126899","DOI":"10.1016\/j.jhazmat.2021.126899","article-title":"Mitochondrial miR-1285 regulates copper-induced mitochondrial dysfunction and mitophagy by impairing IDH2 in pig jejunal epithelial cells","volume":"422","author":"Liao","year":"2022","journal-title":"J Hazard Mater"},{"key":"key20220803125959_b9-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"112901","DOI":"10.1016\/j.ecoenv.2021.112901","article-title":"Gestational arsenic exposure induces anxiety-like behaviors in adult offspring by reducing DNA hydroxymethylation in the developing brain","volume":"227","author":"Lv","year":"2021","journal-title":"Ecotoxicol Environ Saf"},{"key":"key20220803125959_b10-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1182\/blood-2018-05-850826","article-title":"IDH2 inhibition enhances proteasome inhibitor responsiveness in hematological malignancies","volume":"133","author":"Bergaggio","year":"2019","journal-title":"Blood"},{"key":"key20220803125959_b11-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2016.02.017","article-title":"IDH2 deficiency impairs mitochondrial function in endothelial cells and endothelium-dependent vasomotor function","volume":"94","author":"Park","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"key20220803125959_b12-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"731096","DOI":"10.3389\/fendo.2021.731096","article-title":"Identification of isocitrate dehydrogenase 2 (IDH2) mutation in carotid body paraganglioma","volume":"12","author":"Lang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20220803125959_b13-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1158\/2159-8290.CD-13-0083","article-title":"Oncogenic isocitrate dehydrogenase mutations: Mechanisms, models, and clinical opportunities","volume":"3","author":"Cairns","year":"2013","journal-title":"Cancer Discov"},{"key":"key20220803125959_b14-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"100966","DOI":"10.1016\/j.molmet.2020.02.009","article-title":"Wild-type IDH2 contributes to Epstein-Barr virus-dependent metabolic alterations and tumorigenesis","volume":"36","author":"Shi","year":"2020","journal-title":"Mol Metab"},{"key":"key20220803125959_b15-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"639387","DOI":"10.3389\/fonc.2021.639387","article-title":"IDH1\/IDH2 inhibition in acute myeloid leukemia","volume":"11","author":"Cerchione","year":"2021","journal-title":"Front Oncol"},{"key":"key20220803125959_b16-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1182\/blood-2018-08-869008","article-title":"Molecular remission and response patterns in patients with mutant-IDH2 acute myeloid leukemia treated with enasidenib","volume":"133","author":"Stein","year":"2019","journal-title":"Blood"},{"key":"key20220803125959_b17-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1177\/2040620718777467","article-title":"The role of enasidenib in the treatment of mutant IDH2 acute myeloid leukemia","volume":"9","author":"Abou Dalle","year":"2018","journal-title":"Ther Adv Hematol"},{"key":"key20220803125959_b18-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1186\/1471-2407-10-401","article-title":"Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias","volume":"10","author":"Rocquain","year":"2010","journal-title":"BMC Cancer"},{"key":"key20220803125959_b19-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11864-018-0583-4","article-title":"Improving treatment for myelodysplastic syndromes patients","volume":"19","author":"Montoro","year":"2018","journal-title":"Curr Treat Options Oncol"},{"key":"key20220803125959_b20-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1111\/j.1365-2141.2010.08381.x","article-title":"ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia","volume":"151","author":"Gelsi-Boyer","year":"2010","journal-title":"Br J Haematol"},{"key":"key20220803125959_b21-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imr.12246","article-title":"The role of mutations in epigenetic regulators in myeloid malignancies","volume":"263","author":"Woods","year":"2015","journal-title":"Immunol Rev"},{"key":"key20220803125959_b22-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1038\/leu.2015.91","article-title":"Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms","volume":"29","author":"Molenaar","year":"2015","journal-title":"Leukemia"},{"key":"key20220803125959_b23-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"187","DOI":"10.3390\/cancers10060187","article-title":"Evolving treatment strategies for elderly leukemia patients with IDH mutations","volume":"10","author":"Buege","year":"2018","journal-title":"Cancers (Basel)"},{"key":"key20220803125959_b24-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"4931","DOI":"10.1158\/1078-0432.CCR-18-0536","article-title":"Targeting the IDH2 pathway in acute myeloid leukemia","volume":"24","author":"Amaya","year":"2018","journal-title":"Clin Cancer Res"},{"key":"key20220803125959_b25-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41388-022-02193-1","article-title":"Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair","volume":"41","author":"Chen","year":"2022","journal-title":"Oncogene"},{"key":"key20220803125959_b26-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1084\/jem.20092506","article-title":"Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations","volume":"207","author":"Gross","year":"2010","journal-title":"J Exp Med"},{"key":"key20220803125959_b27-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1101\/gad.226613.113","article-title":"Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition","volume":"27","author":"Chen","year":"2013","journal-title":"Genes Dev"},{"key":"key20220803125959_b28-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ccell.2018.04.011","article-title":"Biological role and therapeutic potential of IDH mutations in cancer","volume":"34","author":"Waitkus","year":"2018","journal-title":"Cancer Cell"},{"key":"key20220803125959_b29-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.pharmthera.2017.03.003","article-title":"Isocitrate dehydrogenase (IDH) inhibition as treatment of myeloid malignancies: Progress and future directions","volume":"177","author":"Upadhyay","year":"2017","journal-title":"Pharmacol Ther"},{"key":"key20220803125959_b30-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.stem.2013.12.016","article-title":"Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance","volume":"14","author":"Kats","year":"2014","journal-title":"Cell Stem Cell"},{"key":"key20220803125959_b31-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bcmd.2014.11.017","article-title":"Acquired somatic mutations of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) in preleukemic disorders","volume":"54","author":"Chotirat","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"key20220803125959_b32-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41375-021-01487-9","article-title":"Isocitrate dehydrogenase mutations are associated with altered IL-1\u03b2 responses in acute myeloid leukemia","volume":"36","author":"Sunthankar","year":"2022","journal-title":"Leukemia"},{"key":"key20220803125959_b33-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41408-021-00604-2","article-title":"Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapy","volume":"12","author":"Venugopal","year":"2022","journal-title":"Blood Cancer J"},{"key":"key20220803125959_b34-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12964-020-00536-7","article-title":"Identification of a selective inhibitor of IDH2\/R140Q enzyme that induces cellular differentiation in leukemia cells","volume":"18","author":"Chen","year":"2020","journal-title":"Cell Commun Signal"},{"key":"key20220803125959_b35-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1111\/cas.14152","article-title":"Pharmacological characterization of TQ05310, a potent inhibitor of isocitrate dehydrogenase 2 R140Q and R172K mutants","volume":"110","author":"Gao","year":"2019","journal-title":"Cancer Sci"},{"key":"key20220803125959_b36-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1016\/j.bbrc.2018.08.068","article-title":"Crystal structures of pan-IDH inhibitor AG-881 in complex with mutant human IDH1 and IDH2","volume":"503","author":"Ma","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220803125959_b37-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1158\/2159-8290.CD-16-1034","article-title":"AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations","volume":"7","author":"Yen","year":"2017","journal-title":"Cancer Discov"},{"key":"key20220803125959_b38-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41591-018-0115-6","article-title":"Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib","volume":"24","author":"Quek","year":"2018","journal-title":"Nat Med"},{"key":"key20220803125959_b39-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3349\/ymj.2020.61.9.762","article-title":"All-trans retinoic acid synergizes with enasidenib to induce differentiation of IDH2-mutant acute myeloid leukemia cells","volume":"61","author":"Kim","year":"2020","journal-title":"Yonsei Med J"},{"key":"key20220803125959_b40-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1016\/S1470-2045(21)00494-0","article-title":"Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): A single-arm, phase 1b and randomised, phase 2 trial","volume":"22","author":"DiNardo","year":"2021","journal-title":"Lancet Oncol"},{"key":"key20220803125959_b41-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1182\/blood-2017-04-779405","article-title":"Enasidenib in mutant-IDH2 relapsed or refractory acute myeloid leukemia","volume":"130","author":"Stein","year":"2017","journal-title":"Blood"},{"key":"key20220803125959_b42-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.1234769","article-title":"Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"key20220803125959_b43-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"16458","DOI":"10.1038\/s41598-017-16427-w","article-title":"Allosteric inhibitor remotely modulates the conformation of the orthestric pockets in mutant IDH2\/R140Q","volume":"7","author":"Chen","year":"2017","journal-title":"Sci Rep"},{"key":"key20220803125959_b44-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1016\/j.apsb.2021.03.005","article-title":"Preclinical efficacy against acute myeloid leukaemia of SH1573, a novel mutant IDH2 inhibitor approved for clinical trials in China","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"key20220803125959_b45-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.clml.2015.05.009","article-title":"Prevalence and clinical effect of IDH1 and IDH2 mutations among cytogenetically normal acute myeloid leukemia patients","volume":"15","author":"Aref","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20220803125959_b46-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1182\/bloodadvances.2021004934","article-title":"Differential impact of IDH1\/2 mutational subclasses on outcome in adult AML: Results from a large multicenter study","volume":"6","author":"Middeke","year":"2022","journal-title":"Blood Adv"},{"key":"key20220803125959_b47-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1200\/JCO.2012.47.3314","article-title":"Prognostic score including gene mutations in chronic myelomonocytic leukemia","volume":"31","author":"Itzykson","year":"2013","journal-title":"J Clin Oncol"},{"key":"key20220803125959_b48-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1080\/10428194.2020.1832661","article-title":"Effects of azacitidine in 93 patients with IDH1\/2 mutated acute myeloid leukemia\/myelodysplastic syndromes: A French retrospective multicenter study","volume":"62","author":"Willekens","year":"2021","journal-title":"Leuk Lymphoma"},{"key":"key20220803125959_b49-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10147-019-01462-6","article-title":"Genetic abnormalities and pathophysiology of MDS","volume":"24","author":"Hosono","year":"2019","journal-title":"Int J Clin Oncol"},{"key":"key20220803125959_b50-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00277-011-1352-7","article-title":"IDH1 and IDH2 mutation analysis in Chinese patients with acute myeloid leukemia and myelodysplastic syndrome","volume":"91","author":"Lin","year":"2012","journal-title":"Ann Hematol"},{"key":"key20220803125959_b51-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1038\/leu.2010.52","article-title":"Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS\/myeloproliferative neoplasms","volume":"24","author":"Kosmider","year":"2010","journal-title":"Leukemia"},{"key":"key20220803125959_b52-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/ajh.23596","article-title":"IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution","volume":"89","author":"Lin","year":"2014","journal-title":"Am J Hematol"},{"key":"key20220803125959_b53-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s00432-018-2627-3","article-title":"Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes","volume":"144","author":"Lin","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"key20220803125959_b54-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.clml.2017.06.003","article-title":"TP53 and IDH2 somatic mutations are associated with inferior overall survival after allogeneic hematopoietic cell transplantation for myelodysplastic syndrome","volume":"17","author":"Kharfan-Dabaja","year":"2017","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"key20220803125959_b55-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"e309","DOI":"10.1016\/S2352-3026(19)30284-4","article-title":"Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: A phase 1 subgroup analysis of the multicentre, AG221-C-001 trial","volume":"7","author":"Stein","year":"2020","journal-title":"Lancet Haematol"},{"key":"key20220803125959_b56-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"key20220803125959_b57-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1001\/jamaneurol.2014.1205","article-title":"IDH mutation in glioma: New insights and promises for the future","volume":"71","author":"Turkalp","year":"2014","journal-title":"JAMA Neurol"},{"key":"key20220803125959_b58-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/1878-0261.12182","article-title":"IDH2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer","volume":"12","author":"Li","year":"2018","journal-title":"Mol Oncol"},{"key":"key20220803125959_b59-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1158\/0008-5472.CAN-16-0298","article-title":"IDH2 mutations define a unique subtype of breast cancer with altered nuclear polarity","volume":"76","author":"Chiang","year":"2016","journal-title":"Cancer Res"},{"key":"key20220803125959_b60-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/s41379-019-0254-4","article-title":"The pathological features of angioimmunoblastic T-cell lymphomas with IDH2R172 mutations","volume":"32","author":"Steinhilber","year":"2019","journal-title":"Mod Pathol"},{"key":"key20220803125959_b61-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/1078-0432.CCR-18-4212","article-title":"Genomic profiling identifies association of IDH1\/IDH2 mutation with longer relapse-free and metastasis-free survival in high-grade chondrosarcoma","volume":"26","author":"Zhu","year":"2020","journal-title":"Clin Cancer Res"},{"key":"key20220803125959_b62-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"5030","DOI":"10.3390\/cancers13195030","article-title":"Methylation drivers and prognostic implications in sinonasal poorly differentiated carcinomas","volume":"13","author":"Libera","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20220803125959_b63-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"4535","DOI":"10.1002\/cncr.31039","article-title":"Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications","volume":"123","author":"Miller","year":"2017","journal-title":"Cancer"},{"key":"key20220803125959_b64-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3892\/ol.2014.2013","article-title":"Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms","volume":"7","author":"Qi","year":"2014","journal-title":"Oncol Lett"},{"key":"key20220803125959_b65-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1080\/14737159.2018.1548935","article-title":"The clinical use of IDH1 and IDH2 mutations in gliomas","volume":"18","author":"Picca","year":"2018","journal-title":"Expert Rev Mol Diagn"},{"key":"key20220803125959_b66-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.semcancer.2017.11.010","article-title":"Glioma epigenetics: From subclassification to novel treatment options","volume":"51","author":"Gusyatiner","year":"2018","journal-title":"Semin Cancer Biol"},{"key":"key20220803125959_b67-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/neuonc\/noab153","article-title":"Characterization of systemic immunosuppression by IDH mutant glioma small extracellular vesicles","volume":"24","author":"Ludwig","year":"2022","journal-title":"Neuro Oncol"},{"key":"key20220803125959_b68-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"e539","DOI":"10.1016\/j.wneu.2017.12.112","article-title":"Association between IDH1 and IDH2 mutations and preoperative seizures in patients with low-grade versus high-grade glioma: A systematic review and meta-analysis","volume":"111","author":"Phan","year":"2018","journal-title":"World Neurosurg"},{"key":"key20220803125959_b69-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2015.1.FOCUS14745","article-title":"Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas","volume":"38","author":"Chen","year":"2015","journal-title":"Neurosurg Focus"},{"key":"key20220803125959_b70-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1007\/s11011-018-0278-3","article-title":"Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2","volume":"33","author":"Thirumal Kumar","year":"2018","journal-title":"Metab Brain Dis"},{"key":"key20220803125959_b71-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1080\/10715762.2016.1185519","article-title":"IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: Implications for Parkinson's disease","volume":"50","author":"Kim","year":"2016","journal-title":"Free Radic Res"},{"key":"key20220803125959_b72-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/mc.22573","article-title":"A new functional IDH2 genetic variant is associated with the risk of lung cancer","volume":"56","author":"Li","year":"2017","journal-title":"Mol Carcinog"},{"key":"key20220803125959_b73-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.7150\/thno.21524","article-title":"Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1\u03b1 in lung cancer","volume":"8","author":"Li","year":"2018","journal-title":"Theranostics"},{"key":"key20220803125959_b74-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1595103","DOI":"10.1155\/2017\/1595103","article-title":"Idh2 deficiency exacerbates acrolein-induced lung injury through mitochondrial redox environment deterioration","volume":"2017","author":"Park","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"key20220803125959_b75-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.bbrc.2018.06.078","article-title":"Disruption of IDH2 attenuates lipopolysaccharide-induced inflammation and lung injury in an \u03b1-ketoglutarate-dependent manner","volume":"503","author":"Park","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220803125959_b76-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.3390\/cancers13215526","article-title":"Proteomic profiling differentiates lymphoma patients with and without concurrent myeloproliferative neoplasia","volume":"13","author":"Holst","year":"2021","journal-title":"Cancers (Basel)"},{"key":"key20220803125959_b77-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"15084","DOI":"10.1073\/pnas.1617929114","article-title":"The IDH2 R172K mutation associated with angioimmunoblastic T-cell lymphoma produces 2HG in T cells and impacts lymphoid development","volume":"113","author":"Lemonnier","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20220803125959_b78-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1182\/blood-2015-05-644591","article-title":"IDH2R172 mutations define a unique subgroup of patients with angioimmunoblastic T-cell lymphoma","volume":"126","author":"Wang","year":"2015","journal-title":"Blood"},{"key":"key20220803125959_b79-ol-24-02-13398","first-page":"11753","article-title":"Discordant intracellular and plasma D-2-hydroxyglutarate levels in a patient with IDH2 mutated angioimmunoblastic T-cell lymphoma","volume":"8","author":"Churchill","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20220803125959_b80-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.jmoldx.2018.05.012","article-title":"Multiple ways to detect IDH2 mutations in angioimmunoblastic T-cell lymphoma from immunohistochemistry to next-generation sequencing","volume":"20","author":"Dupuy","year":"2018","journal-title":"J Mol Diagn"},{"key":"key20220803125959_b81-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s40164-021-00200-x","article-title":"Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas","volume":"10","author":"Ye","year":"2021","journal-title":"Exp Hematol Oncol"},{"key":"key20220803125959_b82-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41379-019-0442-2","article-title":"Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: Applications in the diagnosis of tall cell carcinoma with reverse polarity","volume":"33","author":"Pareja","year":"2020","journal-title":"Mod Pathol"},{"key":"key20220803125959_b83-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s10549-019-05459-7","article-title":"The prognostic significance of wild-type isocitrate dehydrogenase 2 (IDH2) in breast cancer","volume":"179","author":"Aljohani","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"key20220803125959_b84-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1096\/fj.201901366R","article-title":"IDH2 reprograms mitochondrial dynamics in cancer through a HIF-1\u03b1-regulated pseudohypoxic state","volume":"33","author":"Wang","year":"2019","journal-title":"FASEB J"},{"key":"key20220803125959_b85-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1038\/modpathol.2016.239","article-title":"Recurrent IDH2 R172X mutations in sinonasal undifferentiated carcinoma","volume":"30","author":"Jo","year":"2017","journal-title":"Mod Pathol"},{"key":"key20220803125959_b86-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/path.4915","article-title":"Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carcinomas","volume":"242","author":"Dogan","year":"2017","journal-title":"J Pathol"},{"key":"key20220803125959_b87-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/PAS.0000000000001420","article-title":"IDH2 mutation analysis in undifferentiated and poorly differentiated sinonasal carcinomas for diagnosis and clinical management","volume":"44","author":"Riobello","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"key20220803125959_b88-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/10520295.2017.1367034","article-title":"Expression patterns of members of the isocitrate dehydrogenase gene family in murine inner ear","volume":"92","author":"Kim","year":"2017","journal-title":"Biotech Histochem"},{"key":"key20220803125959_b89-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1038\/s41598-018-23436-w","article-title":"Loss of IDH2 accelerates age-related hearing loss in male mice","volume":"8","author":"White","year":"2018","journal-title":"Sci Rep"},{"key":"key20220803125959_b90-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/j.bbadis.2018.01.016","article-title":"Isocitrate dehydrogenase 2 deficiency exacerbates dermis damage by ultraviolet-B via \u0394Np63 downregulation","volume":"1864","author":"Ku","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"key20220803125959_b91-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"165523","DOI":"10.1016\/j.bbadis.2019.07.017","article-title":"IDH2 deficiency impairs cutaneous wound healing via ROS-dependent apoptosis","volume":"1865","author":"Kim","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"key20220803125959_b92-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.cell.2012.07.033","article-title":"Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma","volume":"150","author":"Lian","year":"2012","journal-title":"Cell"},{"key":"key20220803125959_b93-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3892\/etm.2012.676","article-title":"Altered expression levels of IDH2 are involved in the development of colon cancer","volume":"4","author":"Lv","year":"2012","journal-title":"Exp Ther Med"},{"key":"key20220803125959_b94-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-12-2587","article-title":"Targeting cancer metabolism","volume":"18","author":"Teicher","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20220803125959_b95-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.redox.2018.04.008","article-title":"IDH2 deficiency accelerates skin pigmentation in mice via enhancing melanogenesis","volume":"17","author":"Park","year":"2018","journal-title":"Redox Biol"},{"key":"key20220803125959_b96-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"e12455","DOI":"10.1111\/jpi.12455","article-title":"Melatonin alleviates adipose inflammation through elevating \u03b1-ketoglutarate and diverting adipose-derived exosomes to macrophages in mice","volume":"64","author":"Liu","year":"2018","journal-title":"J Pineal Res"},{"key":"key20220803125959_b97-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.bbrc.2019.04.069","article-title":"IDH2 protects against nonalcoholic steatohepatitis by alleviating dyslipidemia regulated by oxidative stress","volume":"514","author":"Gong","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220803125959_b98-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41416-020-0852-4","article-title":"Isocitrate dehydrogenase 2 contributes to radiation resistance of oesophageal squamous cell carcinoma via regulating mitochondrial function and ROS\/pAKT signalling","volume":"123","author":"Chen","year":"2020","journal-title":"Br J Cancer"},{"key":"key20220803125959_b99-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2017.09.082","article-title":"Idh2 deficiency accelerates renal dysfunction in aged mice","volume":"493","author":"Lee","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220803125959_b100-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1080\/09553000400007680","article-title":"Role of NADP+-dependent isocitrate dehydrogenase (NADP+-ICDH) on cellular defence against oxidative injury by gamma-rays","volume":"80","author":"Lee","year":"2004","journal-title":"Int J Radiat Biol"},{"key":"key20220803125959_b101-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s12276-020-0451-8","article-title":"Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue","volume":"52","author":"Lee","year":"2020","journal-title":"Exp Mol Med"},{"key":"key20220803125959_b102-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"13385","DOI":"10.1074\/jbc.M700303200","article-title":"Regulation of ionizing radiation-induced apoptosis by mitochondrial NADP+-dependent isocitrate dehydrogenase","volume":"282","author":"Lee","year":"2007","journal-title":"J Biol Chem"},{"key":"key20220803125959_b103-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.bbrc.2013.02.093","article-title":"Silencing of mitochondrial NADP(+)-dependent isocitrate dehydrogenase gene enhances glioma radiosensitivity","volume":"433","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220803125959_b104-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1093\/neuonc\/nos261","article-title":"Overexpression of isocitrate dehydrogenase mutant proteins renders glioma cells more sensitive to radiation","volume":"15","author":"Li","year":"2013","journal-title":"Neuro Oncol"},{"key":"key20220803125959_b105-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1158\/1078-0432.CCR-09-2902","article-title":"IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: A report of the European organization for research and treatment of cancer brain tumor group","volume":"16","author":"van den Bent","year":"2010","journal-title":"Clin Cancer Res"},{"key":"key20220803125959_b106-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00401-010-0645-6","article-title":"The prognostic IDH1 (R132) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma","volume":"119","author":"Bleeker","year":"2010","journal-title":"Acta Neuropathol"},{"key":"key20220803125959_b107-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00775-018-1581-5","article-title":"NADP+-dependent cytosolic isocitrate dehydrogenase provides NADPH in the presence of cadmium due to the moderate chelating effect of glutathione","volume":"23","author":"Cho","year":"2018","journal-title":"J Biol Inorg Chem"},{"key":"key20220803125959_b108-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s12253-016-0076-3","article-title":"The promoting effect of radiation on glucose metabolism in breast cancer cells under the treatment of cobalt chloride","volume":"23","author":"Zhao","year":"2017","journal-title":"Pathol Oncol Res"},{"key":"key20220803125959_b109-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ecoenv.2018.07.062","article-title":"Effects of microplastics and mercury in the freshwater bivalve corbicula fluminea (M\u00fcller, 1774): Filtration rate, biochemical biomarkers and mercury bioconcentration","volume":"164","author":"Oliveira","year":"2018","journal-title":"Ecotoxicol Environ Saf"},{"key":"key20220803125959_b110-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1124\/mol.106.023515","article-title":"Mitochondrial NADP+-dependent isocitrate dehydrogenase protects cadmium-induced apoptosis","volume":"70","author":"Kil","year":"2006","journal-title":"Mol Pharmacol"},{"key":"key20220803125959_b111-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhazmat.2018.11.101","article-title":"Acid stress induces cross-protection for cadmium tolerance of multi-stress-tolerant Pichia kudriavzevii by regulating cadmium transport and antioxidant defense system","volume":"366","author":"Li","year":"2019","journal-title":"J Hazard Mater"},{"key":"key20220803125959_b112-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"124420","DOI":"10.1016\/j.chemosphere.2019.124420","article-title":"Energy metabolism enzymes inhibition by the combined effects of increasing temperature and copper exposure in the coral mussismilia harttii","volume":"236","author":"da Silva Fonseca","year":"2019","journal-title":"Chemosphere"},{"key":"key20220803125959_b113-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"679","DOI":"10.3390\/nu10060679","article-title":"IDH2 deficiency aggravates fructose-induced NAFLD by modulating hepatic fatty acid metabolism and activating inflammatory signaling in female mice","volume":"10","author":"Pan","year":"2018","journal-title":"Nutrients"},{"key":"key20220803125959_b114-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"7242","DOI":"10.18632\/aging.102259","article-title":"Reactive oxygen species-mediated senescence is accelerated by inhibiting Cdk2 in Idh2-deficient conditions","volume":"11","author":"Chae","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"key20220803125959_b115-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"9785","DOI":"10.1038\/s41598-017-10337-7","article-title":"Studies on the regulatory mechanism of isocitrate dehydrogenase 2 using acetylation mimics","volume":"7","author":"Xu","year":"2017","journal-title":"Sci Rep"},{"key":"key20220803125959_b116-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"14078","DOI":"10.1074\/jbc.M112.355206","article-title":"SIRT3 protein deacetylates isocitrate dehydrogenase 2 (IDH2) and regulates mitochondrial redox status","volume":"287","author":"Yu","year":"2012","journal-title":"J Biol Chem"},{"key":"key20220803125959_b117-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"3990","DOI":"10.1158\/0008-5472.CAN-16-2393","article-title":"SIRT3-mediated dimerization of IDH2 directs cancer cell metabolism and tumor growth","volume":"77","author":"Zou","year":"2017","journal-title":"Cancer Res"},{"key":"key20220803125959_b118-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"8677","DOI":"10.1038\/s41598-020-65351-z","article-title":"SIRT3 and GCN5L regulation of NADP+- and NADPH-driven reactions of mitochondrial isocitrate dehydrogenase IDH2","volume":"10","author":"Smolkov\u00e1","year":"2020","journal-title":"Sci Rep"},{"key":"key20220803125959_b119-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"BSR20211005","DOI":"10.1042\/BSR20211005","article-title":"Overexpression of NMNAT3 improves mitochondrial function and enhances antioxidative stress capacity of bone marrow mesenchymal stem cells via the NAD+-Sirt3 pathway","volume":"42","author":"Wang","year":"2022","journal-title":"Biosci Rep"},{"key":"key20220803125959_b120-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.bbrc.2020.08.089","article-title":"SUMOylation enhances the activity of IDH2 under oxidative stress","volume":"532","author":"Yu","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"key20220803125959_b121-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1158\/0008-5472.CAN-14-2200","article-title":"IDH2 and NPM1 mutations cooperate to activate Hoxa9\/Meis1 and hypoxia pathways in acute myeloid Leukemia","volume":"75","author":"Ogawara","year":"2015","journal-title":"Cancer Res"},{"key":"key20220803125959_b122-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"14615","DOI":"10.1074\/jbc.C112.353946","article-title":"Cancer-associated isocitrate dehydrogenase mutations inactivate NADPH-dependent reductive carboxylation","volume":"287","author":"Leonardi","year":"2012","journal-title":"J Biol Chem"},{"key":"key20220803125959_b123-ol-24-02-13398","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.bbrc.2020.02.093","article-title":"Down-regulation of IDH2 sensitizes cancer cells to erastin-induced ferroptosis","volume":"525","author":"Kim","year":"2020","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T10:00:11Z","timestamp":1659520811000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2022.13398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":123,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,6,24]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2022.13398","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"278"}}